Borui Li

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Xiaowu Xu · 5 shared papers, 2024–2026 · strength 1.07
   • Paper SUZ12 promotes pancreatic ductal adenocarcinoma progression and chemoresistance by epigenetically silencing NCOA4-induc… DOI 10.3724/abbs.2025215↗
   • Paper NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis. DOI 10.1002/mc.23645↗
   • Paper Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity … DOI 10.1038/s41401-025-01477-y↗
2. Shunrong Ji · 4 shared papers, 2024–2025 · strength 0.80
   • Paper NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis. DOI 10.1002/mc.23645↗
   • Paper Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity … DOI 10.1038/s41401-025-01477-y↗
   • Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
3. Zheng Li · 3 shared papers, 2024–2026 · strength 0.67
   • Paper SUZ12 promotes pancreatic ductal adenocarcinoma progression and chemoresistance by epigenetically silencing NCOA4-induc… DOI 10.3724/abbs.2025215↗
   • Paper Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity … DOI 10.1038/s41401-025-01477-y↗
   • Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
4. Yi Qin · 3 shared papers, 2024–2025 · strength 0.61
   • Paper NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis. DOI 10.1002/mc.23645↗
   • Paper Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity … DOI 10.1038/s41401-025-01477-y↗
   • Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
5. Xianjun Yu · 3 shared papers, 2024 · strength 0.59
   • Paper NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis. DOI 10.1002/mc.23645↗
   • Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
   • Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
6. Qifeng Zhuo · 3 shared papers, 2024–2025 · strength 0.58
   • Paper Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity … DOI 10.1038/s41401-025-01477-y↗
   • Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
   • Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
7. Chenjie Zhou · 2 shared papers, 2024 · strength 0.38
   • Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
   • Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
8. Xuemin Chen · 1 shared paper, 2026 · strength 0.27
   • Paper SUZ12 promotes pancreatic ductal adenocarcinoma progression and chemoresistance by epigenetically silencing NCOA4-induc… DOI 10.3724/abbs.2025215↗
9. Lei Yin · 1 shared paper, 2026 · strength 0.27
   • Paper SUZ12 promotes pancreatic ductal adenocarcinoma progression and chemoresistance by epigenetically silencing NCOA4-induc… DOI 10.3724/abbs.2025215↗
10. Ye Zeng · 1 shared paper, 2024 · strength 0.22
    • Paper NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis. DOI 10.1002/mc.23645↗
11. Haifeng Hu · 1 shared paper, 2024 · strength 0.22
    • Paper NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis. DOI 10.1002/mc.23645↗
12. Haidi Chen · 1 shared paper, 2024 · strength 0.22
    • Paper NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis. DOI 10.1002/mc.23645↗
13. Di Wu · 1 shared paper, 2025 · strength 0.21
    • Paper Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity … DOI 10.1038/s41401-025-01477-y↗
14. Chenjie Zhou · 1 shared paper, 2025 · strength 0.21
    • Paper Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity … DOI 10.1038/s41401-025-01477-y↗
15. Faliang Xing · 1 shared paper, 2024 · strength 0.20
    • Paper YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic… DOI 10.1016/j.canlet.2024.217197↗
16. Zheng Li · 1 shared paper, 2024 · strength 0.18
    • Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗
17. Ting Wang · 1 shared paper, 2024 · strength 0.18
    • Paper Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via … DOI 10.1111/cpr.13694↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.